CMV Pp65, 561 a.a.

Cytomegalo Virus Pp65(UL83), 561 a.a.Recombinant

The recombinant CMV Pp65 protein, derived from E. coli, has a molecular weight of 62.8 kDa and encompasses the immunodominant regions of CMV Pp65 (UL83), spanning 561 amino acids.
Shipped with Ice Packs
Cat. No.
BT1873
Source
Escherichia Coli.

CMV Mosaic

Cytomegalo Virus Mosaic Recombinant

The E. coli-derived Recombinant Cytomegalo Virus Mosaic protein encompasses multiple epitopes from P150, P52, P38, P65, and P28, resulting in a molecular weight of 40kDa. This Mosaic protein is fused with a 6xHis tag and undergoes purification using a proprietary chromatographic method.
Shipped with Ice Packs
Cat. No.
BT1263
Source
Escherichia Coli.
Appearance
A sterile, colorless solution that has been filtered.

CMV gB

Cytomegalo Virus gB Recombinant

The recombinant CMV gB protein, expressed in E. coli, encompasses amino acids 11-67 of the CMV gB immunodominant region. It is fused to a 26 kDa GST Tag, resulting in a total protein weight of 32.5 kDa (6.5 kDa for CMV gB and 26 kDa for the GST Tag).
Shipped with Ice Packs
Cat. No.
BT1363
Source
Escherichia Coli.

CMV Pp150

Cytomegalo Virus Pp150 (UL32) Recombinant

This recombinant protein, derived from E. coli, encompasses the immunodominant regions of CMV Pp150 (UL32), specifically amino acids 1011 to 1048.
Shipped with Ice Packs
Cat. No.
BT1447
Source
Escherichia Coli.

CMV Pp28

Cytomegalo Virus Pp28 (UL99) Recombinant

This recombinant protein is derived from E. coli and contains the immunodominant regions of CMV Pp28 (UL99), specifically amino acids 130-160.
Shipped with Ice Packs
Cat. No.
BT1544
Source
Escherichia Coli.

CMV Pp38

Cytomegalo Virus Pp38 (UL80a) Recombinant

The recombinant CMV Pp38 protein, derived from E. coli, has a molecular weight of 52.8 kDa. It encompasses the immunodominant regions of CMV Pp38 (UL80a), specifically amino acids 117-373, and is fused to a GST-Tag at the C-terminus.
Shipped with Ice Packs
Cat. No.
BT1611
Source
Escherichia Coli.

CMV Pp52

Cytomegalo Virus Pp52 (UL44) Recombinant

The E. coli-derived recombinant CMV Pp52 protein, with a molecular weight of 51 kDa, encompasses the immunodominant regions of CMV Pp52 (UL44), spanning amino acids 202 to 434. This recombinant CMV-Pp52 protein is fused to a 26 kDa GST tag.
Shipped with Ice Packs
Cat. No.
BT1692
Source
Escherichia Coli.

CMV Pp65

Cytomegalo Virus Pp65 (UL83) Recombinant

The recombinant CMV Pp65 protein, derived from E. coli, has a molecular weight of 52.2 kDa and encompasses the immunodominant regions of CMV Pp65 (UL83), spanning amino acids 297 to 510. A 26 kDa GST tag is fused to the recombinant CMV-Pp65.
Shipped with Ice Packs
Cat. No.
BT1758
Source
Escherichia Coli.
Definition and Classification

Cytomegalovirus (CMV) is a genus of viruses in the order Herpesvirales, within the family Herpesviridae, and the subfamily Betaherpesvirinae . The term “cytomegalo” is derived from Greek, meaning “cell” (cyto-) and “large” (megalo-), reflecting the virus’s ability to cause enlarged cells . CMV includes several species, with Human cytomegalovirus (HCMV) or Human betaherpesvirus 5 (HHV-5) being the most studied .

Biological Properties

CMV is a double-stranded DNA virus with an icosahedral shape, measuring 150 to 200 nm in diameter . It has four fundamental structural elements: an outer lipid envelope, tegument, nucleocapsid, and an internal nucleoprotein core containing its genome . The virus is ubiquitous, with a seroprevalence rate varying widely based on geographic location, age, and socioeconomic status . CMV can infect various human cells, including fibroblasts, epithelial cells, endothelial cells, smooth muscle cells, and monocytes .

Biological Functions

CMV plays a significant role in immune responses and pathogen recognition. It can generate a robust immune response and establish a latent infection in immunocompromised individuals . The virus can evade the immune system by manipulating host cell signaling and immune responses, allowing it to persist in the host . CMV-specific CD8+ cytotoxic T lymphocytes and CD4+ T cells are crucial for controlling primary infection and reactivation from latency .

Modes of Action

CMV interacts with various molecules and cells through complex mechanisms. It can bind to host cell receptors, leading to viral entry and subsequent replication . The virus manipulates host cell signaling pathways to establish and maintain latency, as well as to reactivate when conditions are favorable . CMV’s tegument proteins, such as pp65, play a crucial role in modulating host immune responses and facilitating viral replication .

Regulatory Mechanisms

The expression and activity of CMV are tightly regulated through various mechanisms. Transcriptional regulation involves the interaction of viral proteins with host transcription factors to control viral gene expression . Post-translational modifications, such as phosphorylation and ubiquitination, also play a role in modulating the activity of viral proteins and ensuring efficient viral replication . Additionally, CMV can alter host cell signaling cascades to create a favorable environment for its replication .

Applications in Biomedical Research

CMV has significant applications in biomedical research, diagnostic tools, and therapeutic strategies. It serves as a model for studying viral latency, immune evasion, and host-pathogen interactions . CMV is also used in the development of antiviral drugs and vaccines . Novel approaches, such as gene editing and RNA interference, are being explored to target CMV and prevent its reactivation in immunocompromised individuals . Diagnostic tools, including serology and molecular assays, are essential for detecting CMV infections .

Role in the Life Cycle

CMV plays a crucial role throughout the life cycle, from development to aging and disease. It is acquired early in life, often during childhood, through exposure to infected bodily fluids . The virus establishes a latent infection in various host cells, with periodic reactivations controlled by the immune system . In immunocompromised individuals, CMV reactivation can lead to severe disease, including pneumonia, hepatitis, and retinitis . CMV is also a leading cause of congenital infections, resulting in hearing loss, developmental delays, and other complications in newborns .

© Copyright 2024 Thebiotek. All Rights Reserved.